IP Library › Granted Patent US 7,816,530
Granted Patent B2
US 7,816,530 · App. 12/129,728 · Granted Oct 19, 2010

Piperazinyl compounds

Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,816,530
App. No.
12/129,728
Granted
Oct 19, 2010
Kind
B2
Abstract

Disclosed are new dihydropteridinones of general formula (I) wherein the groups L and R 1 -R 5 have the meanings given in the claims and specification, the isomers thereof, intermediates and processes for preparing these dihydropteridinones and the use thereof as pharmaceutical compositions.

Claims (1)

1. A compound, wherein the compound is cis- or trans-4-(4-cyclopropylmethyl-piperazin-1-yl)-cyclohexylamine:

Assignments (1)
CONFIRMATORY LICENSE Recorded May 21, 2020
From: BOEHRINGER INGELHEIM PHARMA GMBH
To: ONCOHEROES BIOSCIENCES INC.
Reel/Frame 052722/0909 →
Continuity (4)
Division 1121994500 · Sep 6, 2005
Continuation 1090380700 · Jul 30, 2004
Continuation 1037487600 · Feb 26, 2003
Related Publication 20080293944A1 · Nov 27, 2008